LIPITRIN 10 MG / 10 MG 14 TAB

* LIPITRIN 10/10 (Simvastatin + Ezetimibe) 14 Tablets. Lipid Lowering Drug.
* Indications:
  – Primary Hypercholesterolemia:
  Lipitrin is indicated as adjunctive therapy to diet for the reduction of elevated total cholesterol (total-C), low-density
  lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), & non-high-density lipoprotein cholesterol
  (non-HDL-C), & to increase high-density lipoprotein cholesterol (HDL-C) in patients with primary (heterozygous familial &
  non-familial) hypercholesterolemia or mixed hyperlipidemia.
  – Homozygous Familial Hypercholesterolemia (HoFH): Lipitrin is indicated for the reduction of elevated total-C levels in patients
  with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis).
* Dosage & Administration:
  – The patient should be placed on a standard cholesterol-lowering diet before receiving Lipitrin & should continue on this diet
  treatment with Lipitrin.
  – The dosage should be individualized according to the baseline LDL-C level, the recommended goal of therapy, & response.
  – Lipitrin should be taken as a single daily dose in the evening, with or without food.
  – The recommended usual starting dose is 20/10 mg/day.
  – Initiation of therapy with 10/10 mg/day may be considered for patients requiring less aggressive LDL-C reductions.
  – Patients who require a larger reduction in LDL-C (greater than 55%) may be started at 40/10 mg/day.
  – After initiation of therapy, Lipid levels may be analyzed after 2 or more weeks & dosage adjusted, if needed.
  – Dosage in Patients with Homozygous Familial Hypercholesterolemia: The recommended dosage is Lipitrin 40/10 mg/day
  or 80/10 mg/day in the evening. Lipitrin should be used as an adjunct to other lipid-lowering treatments (e.g. LDL apheresis)
  in these patients or if such treatments are unavailable.
  – Use in the elderly: No dosage adjustment is required for elderly patients.
* Store below 30 degrees C.
* Produced by: Chemipharm Pharmaceutical Industries S.A.E. – Egypt.